Cargando…
Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261438/ https://www.ncbi.nlm.nih.gov/pubmed/34295758 http://dx.doi.org/10.21037/tau-20-1254 |
_version_ | 1783719013053890560 |
---|---|
author | Beckmann, Kerri Cahill, Declan Brown, Christian Van Hemelrijck, Mieke Kinsella, Netty |
author_facet | Beckmann, Kerri Cahill, Declan Brown, Christian Van Hemelrijck, Mieke Kinsella, Netty |
author_sort | Beckmann, Kerri |
collection | PubMed |
description | BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite high dropout rates, few studies have purposively explored the opinions and experiences of men who discontinued AS. The aim of this study was to gain insight into the reasons why some men on AS for PCa discontinue active treatment without evidence of disease progression. METHODS: Semi-structured interviews were undertaken with 14 men from diverse socio-cultural backgrounds who had been on AS for PCa but dropped out of surveillance to undergo active treatment without signs of disease progression. Purposive sampling to reach data saturation was used to select participants based on their experience of AS and willingness to share their experiences. Interviews were transcribed and analysis undertaken in an inductive thematic manner. RESULTS: The following themes arose from interviews as factors that potentially influence adherence to AS: men’s experience at diagnosis and follow-up consultations, involvement in shared decision-making, the extent of supportive care and information, administrative procedures and support from partner and peers. A poor experience during diagnosis could adversely influence long-term adherence to AS, given the same diagnostic tests are frequently repeated. The provision of consistent information and support while on AS, similar to that offered to men undergoing radical treatment, was also highlighted as being important to increase confidence in the process. CONCLUSIONS: Effective communications skills among health professionals, aimed at building trust in patient-clinician relationships, providing opportunities for shared decision-making and developing self-efficacy, along with structured information and support, are key to enhancing long-term adherence to AS. |
format | Online Article Text |
id | pubmed-8261438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-82614382021-07-21 Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer Beckmann, Kerri Cahill, Declan Brown, Christian Van Hemelrijck, Mieke Kinsella, Netty Transl Androl Urol Original Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite high dropout rates, few studies have purposively explored the opinions and experiences of men who discontinued AS. The aim of this study was to gain insight into the reasons why some men on AS for PCa discontinue active treatment without evidence of disease progression. METHODS: Semi-structured interviews were undertaken with 14 men from diverse socio-cultural backgrounds who had been on AS for PCa but dropped out of surveillance to undergo active treatment without signs of disease progression. Purposive sampling to reach data saturation was used to select participants based on their experience of AS and willingness to share their experiences. Interviews were transcribed and analysis undertaken in an inductive thematic manner. RESULTS: The following themes arose from interviews as factors that potentially influence adherence to AS: men’s experience at diagnosis and follow-up consultations, involvement in shared decision-making, the extent of supportive care and information, administrative procedures and support from partner and peers. A poor experience during diagnosis could adversely influence long-term adherence to AS, given the same diagnostic tests are frequently repeated. The provision of consistent information and support while on AS, similar to that offered to men undergoing radical treatment, was also highlighted as being important to increase confidence in the process. CONCLUSIONS: Effective communications skills among health professionals, aimed at building trust in patient-clinician relationships, providing opportunities for shared decision-making and developing self-efficacy, along with structured information and support, are key to enhancing long-term adherence to AS. AME Publishing Company 2021-06 /pmc/articles/PMC8261438/ /pubmed/34295758 http://dx.doi.org/10.21037/tau-20-1254 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) Beckmann, Kerri Cahill, Declan Brown, Christian Van Hemelrijck, Mieke Kinsella, Netty Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title | Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title_full | Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title_fullStr | Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title_full_unstemmed | Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title_short | Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
title_sort | understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer |
topic | Original Article on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261438/ https://www.ncbi.nlm.nih.gov/pubmed/34295758 http://dx.doi.org/10.21037/tau-20-1254 |
work_keys_str_mv | AT beckmannkerri understandingreasonsfornonadherencetoactivesurveillanceforlowintermediateriskprostatecancer AT cahilldeclan understandingreasonsfornonadherencetoactivesurveillanceforlowintermediateriskprostatecancer AT brownchristian understandingreasonsfornonadherencetoactivesurveillanceforlowintermediateriskprostatecancer AT vanhemelrijckmieke understandingreasonsfornonadherencetoactivesurveillanceforlowintermediateriskprostatecancer AT kinsellanetty understandingreasonsfornonadherencetoactivesurveillanceforlowintermediateriskprostatecancer |